Perspectives on salvage therapy for non-small-cell lung cancer.

Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients.

Allelic loss on chromosomes 2q21 and 19p 13.2 in oxyphilic thyroid tumors.